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OBJECTIVE: To report our initial institutional experience with fetoscopic laser photocoagulation of placental anastomoses in 
severe twin-twin transfusion syndrome using a 1.0 mm endoscope. 
METHODS: Between July 2006 and June 2008, 19 monochorionic diamniotic twin pregnancies complicated by severe TTTS 
(Quintero stages III and IV) underwent fetoscopic laser therapy. Perinatal data were prospectively collected and compared accord-
ing to the Quintero stages.
RESULTS: Nine patients were classified as stage III and ten as stage IV. The Mean gestational ages at diagnosis and procedure were 
20 (range: 17-25) and 22.0 (range: 19.0-26.0) weeks, respectively, with no statistical difference between the two groups. Preterm 
premature rupture of the membranes occurred in two cases (10.5%), and spontaneous preterm delivery in eight (42.1%). Overall 
mean gestational age at delivery was 32.1 (range: 26.0-38.0) weeks. Prematurity was more severe in stage IV patients (p<0.01). 
Among all cases, the overall survival rate was 52.6%, and the percentages of pregnancies with survival of both babies and at least 
one twin were 26.3% and 78.9%, respectively. In the case of stage III patients, the overall survival rate was 61.1%. Of the stage III 
pregnancies, 33.3% resulted in both babies surviving, and 88.9% of these pregnancies resulted in at least one surviving twin. For 
stage IV, as the corresponding statistics were 45.0%, 20.0% and 70.0% respectively. 
CONCLUSIONS: Our initial institutional experience with 1.0 mm fetoscopic laser therapy for severe TTTS showed results similar 
to those reported in the literature for larger endoscopes.
KEYWORDS: Twin-twin transfusion syndrome; Fetal surgery; Fetoscopy; Prenatal diagnosis; Laser; Fetal therapy; Placenta; 
Monochorionic twins.
INTRODUCTION
Monochorionic twin pregnancies represent a high-risk 
group for adverse obstetric outcomes.1 In approximately 10% 
of monochorionic twin pregnancies, unbalanced inter-twin 
blood flow along placental vascular anastomoses can cause 
twin-twin transfusion syndrome (TTTS).2,3 Left untreated, 
the prognosis is poor, with high perinatal mortality rates of 
80-100% and a substantial risk of neurological sequelae in 
survivors.4,5
Numerous prenatal treatment options for TTTS have 
been reported including amnioreduction (AR),6-9 inter-twin 
septostomy,10-14 nonselective fetoscopic laser ablation15-17 and 
selective laser photocoagulation of placental anastomoses.18-26 
Although the pathophysiology of the disease is poorly 
understood, TTTS is attributed to unbalanced inter-twin blood 
flow along superficial placental anastomoses. Therefore, 
fetoscopic laser photocoagulation of inter-twin superficial 
placental anastomoses has been described as the best option 
for prenatal treatment of TTTS.18-25 This prenatal procedure 
was first described by De Lia et al.26 in 1990 as a means of 
functionally occluding vascular connections responsible for 
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the syndrome. Many controversial results have been reported 
in the literature, but multiple studies suggest that fetoscopic 
laser photocoagulation of superficial placental anastomoses 
remains the best option for severe TTTS.19,22,24,25 In 2004, Senat 
et al.19 demonstrated that fetoscopic laser photocoagulation of 
placental anastomoses was a more effective first-line treatment 
than serial amnioreduction. In general, the percentages of 
pregnancies with survival of both fetuses vary from 40% to 
60%. The rate for survival of at least one twin ranges from 
70% to 90%. This variation in perinatal outcome might be 
explained by different stages of TTTS. 
The severity of the disease is usually assessed by 
the Quintero staging system:27 Stage I is defined as 
oligohydramnios (deepest vertical pool ≤ 2cm) in the 
donor and polyhydramnios (deepest vertical pool ≥ 8cm) 
in the recipient; Stage II is denoted by donor anuria 
(anamnios and absence of fetal bladder - “stuck twin”); 
Stage III is characterized by critically abnormal Doppler 
ultrasonography in either the arterial system of the donor or 
the venous system of the recipient; Stage IV is present when 
there is fetal hydrops; and Stage V occurs with the mortality 
of one or both twins.
To the best of our knowledge, most centers use 
endoscopes of 2.0 to 3.0 mm to guide the fetoscopic laser 
ablation of superficial placental anastomoses, and there have 
been no previous reports of the use of a narrower endoscope 
for this procedure. 
Therefore, the objective of the present study was 
to report our initial clinical experience with fetoscopic 
laser photocoagulation for severe TTTS using a 1.0 mm 
endoscope, focusing on perinatal outcomes and maternal 
complications consistent with the Quintero staging 
standard.
METHODS AND PATIENTS
From July 2006 to June 2008, a prospective study was 
conducted in a tertiary fetal medicine center. Fetoscopic 
laser photocoagulation was performed in 19 monochorionic 
diamniotic twin pregnancies complicated by severe TTTS. 
All patients were referred from obstetricians or other 
fetal medicine centers. All patients gave written consent 
after extensive counseling. This protocol was approved 
by the local ethical committees. Before laser treatment, 
detailed fetal morphological ultrasound examination and 
echocardiography were performed in order to assess fetal 
biometry, anomalies, deepest vertical pool, placental location 
and Doppler sonography of the umbilical arteries, middle 
cerebral arteries and ductus venosus.
Inclusion criteria for fetoscopic laser photocoagulation 
were: monochorionic diamniotic pregnancies complicated 
with severe TTTS (polyhydramnios in the recipient twin’s 
amniotic cavity with the deepest vertical pool ≥ 8 cm and 
oligohydramnios in the donor twin with the deepest vertical 
pool ≤ 2 cm; Stages III and IV according to the Quintero 
classification27) at a gestational age of less than 26 weeks. 
Exclusion criteria were fetal death, fetal malformation before 
procedure, rupture of membranes and preterm labor. During 
the study period, fetoscopic laser therapy was not offered 
for Stage I TTTS. 
Fetoscopic laser therapy of the superficial placental 
anastomoses was performed under local maternal 
anesthesia (20 ml of 1% lidocaine injected into the skin 
and subcutaneous tissue) followed by percutaneous 
insertion into the amniotic cavity of a 2.2 mm specially 
designed trocar with two separate work channels for a 1 
mm fetoscope (11510 A, Storz, Tuttlingen, Germany) and 
a 0.6 mm neodymium fiber, to allow the use of yttrium-
aluminum-garnet or diode laser equipment. In pregnancies 
with a completely anterior placenta, we used a 30° trocar of 
the same size and diameter. Superficial inter-twin placental 
anastomoses were directly identified (Figure 1a) and 
coagulated (Figures 1b-d). At the end of the selective laser 
ablation procedure, amniotic fluid was drained through the 
sheath after removing the fetoscope until a vertical pool 
of 4-6 cm was confirmed under ultrasound. Prophylactic 
tocolytics and antibiotics were administered perioperatively. 
All the patients were hospitalized for 24 to 48 hours after 
the procedure and were followed by weekly ultrasound 
examinations. 
The following prenatal and neonatal data were collected 
prospectively: gestational age at diagnosis, gestational age at 
fetoscopic laser photocoagulation, survival rates (either both 
fetuses or at least one twin), fetal mortality and neurological 
morbidity (intraventricular hemorrhage, periventricular 
Figure 1 - (a) Fetoscopic view of superficial inter-twin vascular anastomoses 
in a TTTS stage III pregnancy at 22 weeks of gestation. (b,d) Fetoscopic 
laser photocoagulation of superficial inter-twin anastomoses.
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leukomalacia, ventriculomegaly or cerebral palsy) during 
hospitalization for up to 30 days. All data were analyzed 
according to the Quintero stage. Categorical variables such 
as survival and stage were analyzed using the χ2 test. Interval 
variables such as gestational age were analyzed using the 
Student’s t test. Statistical significance was confirmed when 
p ≤ 0.05.
RESULTS
A total of 23 monochorionic diamniotic pregnancies 
met the initial inclusion criteria. However, three patients 
were excluded because preterm labor occurred before the 
laser procedure could be performed. One additional patient 
was excluded because she was bearing triplets. For the 19 
pregnancies that were included in the present study, severe 
TTTS (stages III and IV) was confirmed using ultrasound 
examination. The mean gestational age at diagnosis was 20 
(range: 17-25) weeks. Nine pregnancies were classified as 
stage III, and ten as stage IV. 
The mean gestational age at fetoscopic laser ablation 
was 22.0 (range: 19.0-26.0) weeks. There was no statistical 
difference in gestational age at the time of the procedure 
between patients with TTTS stage III (mean: 21.0; range: 
20.0-25.0) and those with stage IV (mean: 22.0; range: 
19.0-26.0; p=0.38). The number of anastomoses coagulated 
per procedure varied from 7 to 13 and was similar in both 
groups (p=0.42). The placenta was posterior in 10/19 
(52.6%) pregnancies and anterior in 9/19 (47.4%). In the 
present study, a second fetoscopic laser coagulation was 
not required for any of the cases. There were no serious 
maternal complications during or after fetoscopy. There was 
no need for blood transfusion, laparotomy or admission to 
an intensive care unit. 
Preterm premature rupture of the membranes (PPROM) 
occurred in 2/19 (10.5%) pregnancies (one was a TTTS 
stage III patient and the other was stage IV). In the first case, 
PPROM occurred two weeks after the procedure, which was 
performed at 24 weeks of gestation. At 26 weeks, the patient 
delivered vaginally and both twins died on the second day 
of life. A second patient with stage III TTTS underwent 
fetoscopic laser therapy at 25 weeks. PPROM occurred seven 
weeks after fetoscopic laser therapy. The patient delivered 
one baby who is currently healthy (the donor twin died two 
days after laser therapy).
Recurrence of polyhydramnios in the recipient’s amniotic 
sac occurred in 3/19 (15.8%) pregnancies in which both 
twins survived after fetoscopic laser photocoagulation. In 
one patient, polyhydramnios recurred eight weeks after 
the procedure, and two amnioreductions were performed. 
The donor, who had already exhibited ventriculomegaly 
before the laser procedure, died in utero at 30 weeks 
of gestation. A Caesarean section was performed at 32 
weeks; the recipient is currently healthy. In another patient, 
recurrence of polyhydramnios was observed four weeks 
after fetoscopic laser coagulation, and three amnioreductions 
were performed; the donor died in utero at 29 weeks. A 
Caesarean section was performed because of fetal distress 
and meconium at 31 weeks. The recipient died two days 
after birth. In a third patient, recurrent polyhydramnios 
was diagnosed three weeks after the procedure and three 
amnioreductions were performed. In this patient, tocolytic 
medication (beta-agonist) was used continuously from 22 
to 26 weeks, and a Caesarean section was performed at 26 
weeks of gestation. However, the recipient died one day after 
birth and the donor one week later.
Spontaneous preterm labor occurred in 8/19 (42.1%) 
pregnancies. In a further 5/19 (26.3%) pregnancies, patients 
were delivered prematurely before 32 weeks because of 
fetal distress. The overall mean gestational age at delivery 
was 32.1 (range: 26.0-38.0) weeks of gestation. Prematurity 
was more severe among pregnancies with stage IV disease 
(mean: 31.3 weeks; range: 26.0 - 36.0) than among those 
classified as stage III (mean: 33.8 weeks; range: 30.0 - 38.0; 
p<0.01).
Perinatal results are shown in Table 1. The overall 
survival rate was 52.6% (20/38). The percentage of 
pregnancies in which both twins survived was 26.3% 
(5/19). Survival of only one twin occurred in 52.6% of cases 
(10/19), thus resulting in a survival rate for at least one 
baby of 78.9% (15/19). The survival rates for recipient and 
donor twins were similar at 52.6% (10/19). Recipient fetal 
mortality occurred in 31.6% (6/19) of cases while mortality 
of the donor fetus occurred in 36.8% (7/19). Neonatal 
deaths occurred in 3/19 (15.8%) of recipient babies and in 
2/19 (10.5%) of donor babies. Among all survivors (n=20), 
there was no intraventricular hemorrhage, periventricular 
leukomalacia, ventriculomegaly or cerebral palsy detected at 
up to 30 days of life. In one case, a disproportionally smaller 
right leg of the recipient twin was noted at birth after 29 
weeks of gestation (the donor died one day after fetoscopic 
laser therapy at 26 weeks).
According to the Quintero stages, there was a tendency 
for increased perinatal survival for stage III TTTS as 
compared to stage IV cases; however this difference did not 
reach statistical significance (Table 1). There was no cerebral 
morbidity among the 17 babies that survived. 
DISCUSSION
This study presents our initial institutional experience 
with fetoscopic laser photocoagulation for the treatment of 
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severe TTTS using a smaller diameter cannula and fetoscope 
than has been utilized in previous reports. Although the 
results presented here were obtained during our initial 
experience and represent elements of a learning curve, they 
are encouraging since they are similar to those reported 
from experienced referral centers in the United States and 
Europe.19-25 
Fetoscopic laser photocoagulation is usually performed 
using endoscopes from 1.2 mm to 3.3 mm in diameter that 
directly visualize the vessels on the placental surface. Once 
these inter-twin communicating vessels are identified, they 
are photocoagulated using laser energy. In our study, we 
used a smaller fetoscope and cannula of 1.0 mm and 2.2 
mm, respectively. To the best of our knowledge, this is 
the first report in which this less invasive technique was 
performed in all cases and even at gestational ages of longer 
than 21 weeks. One advantage of using a narrower cannula 
and endoscope might be the lower risk for premature 
rupture of the membranes and preterm labor. Additionally, 
the narrower apparatus might reduce maternal discomfort 
during procedures performed with local skin anesthesia. 
For these reasons, we decided to try this less invasive 
technique. However, several disadvantages of using a 
narrower and shorter endoscope have been suggested, 
including lower image quality, which was not observed in 
our study, and limited assessment of the deepest fetal or 
placental structures. In severe TTTS, this limitation is of 
particular concern when the placenta is posteriorly located 
and a severe polyhydramnios is present. In this situation, a 
slight amnioreduction was performed to reduce the distance 
between the tip of the endoscope and the placenta, thereby 
allowing assessment of superficial placental structures with 
the endoscope. Thus, placental superficial anastomoses were 
clearly identified in all cases in the present study.
Many studies that assess this type of treatment, including 
a recent meta-analysis,24,25 do not classify the severity of 
TTTS. However, it seems that laser therapy is superior to 
amnioreduction for stages II through IV.19-29 The optimal 
treatment for Stage I disease has not been determined. 
O’Donoghue et al. 30 reported their observational experience 
for 46 pregnancies with stage I TTTS and found that the 
disease remained stable or regressed in 69.6% of cases. 
Survival rates were superior when compared to cases that 
progressed to at least stage III (30.4%). However, a factor 
that could predict the progression of the disease was not 
identified. Huber et al.31 reported that even in cases of stage 
I TTTS, laser therapy is associated with improved perinatal 
outcomes. 
We only applied our fetoscopic laser protocol to severe 
cases for two reasons. First, it is preferable to limit a new 
therapeutic option to only the most severe cases while an 
institution’s healthcare workers are still becoming familiar 
with the new procedure. This logic is supported by the 
literature - indeed, laser therapy was initially only performed 
for stages II through IV. Many investigators have recently 
suggested that fetoscopic laser therapy might be associated 
with improved perinatal outcomes even for stage I patients;31 
in fact, it appears that the best results are achieved for stages I 
and II. The second reason that we only included TTTS stages 
III and IV was the late diagnosis and referral to our unit; 
these factors probably explain the high frequency of stage IV 
disease in our series as compared to other published reports.
Our results are very similar to recent reports for stage 
III and IV patients (Table 2). For stage III, survival of at 
least one baby and both twins has been reported to range 
between 76.2% and 82.5% and between 19.1% and 53.8%, 
respectively.19,31-33 This compares to the rates of 88.9% and 
33.3%, respectively, observed in the present study. For stage 
Table 1 - Perinatal results of 19 pregnancies with TTTS stages III and IV treated with fetoscopic laser photocoagulation
 Quintero stage
p value
All cases III IV
Gestational age at procedure 22.0 (19.0 - 26.0) 22.0 (20.0 - 25.0) 21.9 (19.0 - 26.0) 0.38
Gestational age at delivery 32.1 (26.0 - 38.0) 33.8 (30.0 - 38.0) 31.3 (26.0 - 36.0) <0.01
Overall survival rate 20/38 (52.6%) 11/18 (61.1%) 9/20 (45.0%) 0.32
At least 1 survivor 15/19 (78.9%) 8/9 (88.9%) 7/10 (70.0%) 0.31
One survivor 10/19 (52.6%) 5/9 (55.6%) 5/10 (50.0%) 0.81
Both survivors 5/19 (26.3%) 3/9 (33.3%) 2/10 (20.0%) 0.51
Donor intrautero death 7/19 (36.8%) 4/9 (44.4%) 3/10 (30.0%) 0.51
Recipient intrautero death 6/19 (31.6%) 1/9 (11.1%) 5/10 (50.0%) 0.07
Donor neonatal death 2/19 (10.5%) 1/9 (11.1%) 1/10 (10.0%) 0.94
Recipient neonatal death 3/19 (15.8%) 1/9 (11.1%) 2/10 (20.0%) 0.59
* Means (range) – t student test; ** Number (percentage) - χ2 test; Survival rate is considered up to 30 days of life
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IV TTTS, the reported survival of at least one baby and both 
twins is between 66.7% and 81.8% and 33.3% and 50.0%, 
respectively.19,31-33 In the current study, our rates of survival 
were 70.0% and 20.0%, respectively. 
Our results are encouraging since they were obtained 
while our caregiver teams were still on the learning curve for 
this new procedure. The main problem in our series was that 
patients were referred too late, and thus presented with more 
severe complications. Although terminations of pregnancy 
and selective reductions have been reported as management 
options for severe TTTS in some series, termination was not 
performed in any of our cases. Obstetric complications such 
as PPROM and spontaneous preterm labor occurred with 
similar frequencies to those described in literature.29, 34 
In conclusion, our initial institutional experience using 
a narrower endoscope for fetoscopic laser photocoagulation 
treatment of severe TTTS can be considered encouraging 
since we observed similar rates of obstetric complications 
and perinatal survival to those reported in literature. 
Therefore, we conclude that narrower and more delicate 
instruments can be used for endoscopic laser therapy in 
severe TTTS.
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Table 2 - Comparison between our perinatal outcomes and those reported in the literature
  0 survivor 1 survivor 2 survivors At least 1 survivor
N (%) N (%) N (%) N (%)
Quintero et al. 2003 32 Stage III 6/28 (21.5%) 15/28 (53.6%) 7/28 (25.0%) 22/28 (78.6%)
Stage IV 2/11 (18.2%) 4/11 (36.4%) 5/11 (45.5%) 9/11 (81.8%)
Senat et al. 2004 19 Stage III NR NR NR 23/35 (65.7%)
Stage IV NR NR NR
Huber et al. 2006 31 Stage III 14/80 (17.5%) 23/80 (28.7%) 43/80 (53.8%) 66/80 (82.5%)
Stage IV 3/10 (30.0%) 2/10 (20.0%) 5/10 (50.0%) 7/10 (70.0%)
Sepulveda et al. 2007 33 Stage III 5/21(23.8%) 12/21(57.1%) 4/21 (19.1%) 16/21 (76.2%)
Stage IV 1/3 (33.3%) 1/3 (33.3%) 1/3 (33.3%) 2/3 (66.7%)
The present study Stage III 1/9 (11.1%) 5/9 (55.6%) 3/9 (33.3%) 8/9 (88.9%)
Stage IV 3/10 (30.0%) 5/10 (50.0%) 2/10 (20.0%) 7/10 (70.0%)
NR: not reported
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